Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TSX VENTURE EXCHANGE  >  ImmunoPrecise Antibodies Ltd.    IPA   CA45257F2008

IMMUNOPRECISE ANTIBODIES LTD.

(IPA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo ImmunoPrecise Antibodies Ltd.
Immunoprecise Antibodies Ltd, formerly Tanqueray Exploration Ltd, is a Canada-based supplier of custom hybridoma development services. The Company's geographical segments include United States of America and Canada. It offers products, such as antibodies and hybridoma licensing. It offers various services, such as ImmunoProtect, Monoclonal Development, Polyclonal Development, Antibody Protection, Peptide Production and Cryopreservation Services. Its antibody products include IPA006A, IPA006B and IPA006F, which it offers to the research and industrial community. Its hybridoma licensing products include Anti-Human P38a (MAPKinase) Monoclonal Antibody Hybridoma Cell Line and Anti-Acetylated Lysine Monoclonal Antibody Hybridoma Cell Line. It offers cryopreservation storage service for the secure storage of users' valuable biological materials, including hybridoma clones, plasmid constructs and cell lines. It also offers both peptide synthesis and protein carrier conjugation services.
Sales per Business
20192020Delta
CAD (in Million)%CAD (in Million)%
Project10.5096.1%13.2093.9% +25.7%
Antibodies0.2051.9%0.7395.3% +261.5%
Cryo Storage0.2252.1%0.1240.9% -44.96%
Sales per region
20192020Delta
CAD (in Million)%CAD (in Million)%
Europe5.8053.1%6.1143.5% +5.49%
United States3.8535.2%5.9542.3% +54.53%
Other0.4213.8%1.289.1% +204.27%
Canada0.8597.9%0.7155.1% -16.83%
Managers and Directors
NameAgeSinceTitle
Jennifer Bath, Dr.-2018President, Chief Executive Officer & Director
James S. Kuo, Dr.542016Chairman
Lisa Helbling-2019Chief Financial Officer
Yasmina Noubia Abdiche, Dr.-2020Chief Scientific Officer
Gregory S. Smith532016Independent Director
Robert D. Burke, Dr.-2017Independent Director
Paul Andreola562018Independent Director
Brian Lundstrom572019Director
Kari Graber--VP-Client Relations & Project Management
Stefan Lang, Dr.-2019Chief Business Officer
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,036,525 15,742,811 92.4% 0 0.0% 92.4%
Shareholders
NameEquities%
Paul Andreola 1,236,600 7.36%
Miko Malberg 815,600 4.85%
NameSilo Technologies Corp. 560,000 3.33%
Martin Hessing 94,644 0.56%
Gradient Capital Advisors LLC 21,718 0.13%
StoneCastle Investment Management, Inc. 20,620 0.12%
Robert D. Burke 16,600 0.099%
Brian Lundstrom 13,800 0.082%
Gregory S. Smith 10,000 0.059%
Jennifer Bath 9,434 0.056%
Company contact information
ImmunoPrecise Antibodies Ltd.
4464 Markham Street
Suite 3204
Victoria, BC V8Z 7X8

Phone : +1.250.483.0308
Fax : +1.604.684.0642
Web : http://www.immunoprecise.com